Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
45.37
+1.08 (2.44%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $4.93 billion as of March 10, 2026. Its market cap has increased by 1,348.40% in one year.
Market Cap
4.93B
Enterprise Value
4.74B
1-Year Change
1,348.40%
Ranking
Category
Stock Price
$45.37
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $4.93B, an increase of 3,330.92%. That is a compound annual growth rate of 100.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.82B | 9.63% |
| Dec 31, 2025 | 4.39B | 833.82% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 5.38B |
| Caris Life Sciences | 5.37B |
| Mirum Pharmaceuticals | 5.36B |
| Celcuity | 5.25B |
| Xenon Pharmaceuticals | 5.22B |
| CG Oncology | 5.18B |
| Apogee Therapeutics | 5.16B |
| Scholar Rock Holding | 5.08B |